Intermedical Care and Lab Hospital Public Company Limited (IMH) Stock Statistics & Valuation Metrics
Total Valuation
Intermedical Care and Lab Hospital Public Company Limited has a market cap or net worth of THB 763.15M. The enterprise value is THB 1.81B.
- Market Cap
- THB 763.15M
- Enterprise Value
- THB 1.81B
Share Statistics
Intermedical Care and Lab Hospital Public Company Limited has 237,002,430 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 237,002,430
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Intermedical Care and Lab Hospital Public Company Limited’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -7.42%.
- Return on Equity (ROE)
- -0.35
- Return on Assets (ROA)
- -0.09
- Return on Invested Capital (ROIC)
- -7.42%
- Return on Capital Employed (ROCE)
- -0.09
- Revenue Per Employee
- 2.16M
- Profits Per Employee
- -539.13K
- Employee Count
- 350
- Asset Turnover
- 0.36
- Inventory Turnover
- 28.45
Valuation Ratios
The current PE Ratio of Intermedical Care and Lab Hospital Public Company Limited is -11.21. Intermedical Care and Lab Hospital Public Company Limited’s PEG ratio is -0.26.
- PE Ratio
- -11.21
- PS Ratio
- 0.92
- PB Ratio
- 1.25
- Price to FCF
- 9.70
- Price to Operating Cash Flow
- 7.97
- PEG Ratio
- -0.26
Income Statement
In the last 12 months, Intermedical Care and Lab Hospital Public Company Limited had revenue of 754.92M and earned -188.69M in profits. Earnings per share was -0.83.
- Revenue
- 754.92M
- Gross Profit
- 101.66M
- Operating Income
- -134.80M
- Pretax Income
- -182.94M
- Net Income
- -188.69M
- EBITDA
- -78.98M
- Earnings Per Share (EPS)
- -0.83
Cash Flow
In the last 12 months, operating cash flow was 93.35M and capital expenditures -16.63M, giving a free cash flow of 76.72M billion.
- Operating Cash Flow
- 93.35M
- Free Cash Flow
- 76.72M
- Free Cash Flow per Share
- 0.32
Dividends & Yields
Intermedical Care and Lab Hospital Public Company Limited pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 10.31%
- Earnings Yield
- -8.92%
Stock Price Statistics
- Beta
- 0.16
- 52-Week Price Change
- -16.15%
- 50-Day Moving Average
- 3.35
- 200-Day Moving Average
- 3.12
- Relative Strength Index (RSI)
- 44.89
- Average Volume (3m)
- 84.85K
Important Dates
Intermedical Care and Lab Hospital Public Company Limited upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 17, 2026
- Next Earnings Date
- Nov 17, 2026
- Ex-Dividend Date
- ―
Financial Position
Intermedical Care and Lab Hospital Public Company Limited as a current ratio of 0.40, with Debt / Equity ratio of 199.38%
- Current Ratio
- 0.40
- Quick Ratio
- 0.36
- Debt to Market Cap
- 0.92
- Net Debt to EBITDA
- -13.34
- Interest Coverage Ratio
- -2.37
Taxes
In the past 12 months, Intermedical Care and Lab Hospital Public Company Limited has paid 11.62M in taxes.
- Income Tax
- 11.62M
- Effective Tax Rate
- -0.06
Enterprise Valuation
Intermedical Care and Lab Hospital Public Company Limited EV to EBITDA ratio is 31.72, with an EV/FCF ratio of 23.05.
- EV to Sales
- 2.18
- EV to EBITDA
- 31.72
- EV to Free Cash Flow
- 23.05
- EV to Operating Cash Flow
- 18.94
Balance Sheet
Intermedical Care and Lab Hospital Public Company Limited has THB 7.50M in cash and marketable securities with THB 1.03B in debt, giving a net cash position of -THB 1.02B billion.
- Cash & Marketable Securities
- THB 7.50M
- Total Debt
- THB 1.03B
- Net Cash
- -THB 1.02B
- Net Cash Per Share
- -THB 4.32
- Tangible Book Value Per Share
- -THB 0.06
Margins
Gross margin is 23.35%, with operating margin of 7.53%, and net profit margin of -8.18%.
- Gross Margin
- 23.35%
- Operating Margin
- 7.53%
- Pretax Margin
- -5.78%
- Net Profit Margin
- -8.18%
- EBITDA Margin
- 6.87%
- EBIT Margin
- 8.26%
Analyst Forecast
The average price target for Intermedical Care and Lab Hospital Public Company Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 5.56%
- EPS Growth Forecast
- 58.10%

